低分子药物研发的全球市场预测:各治疗领域，流程 / 各阶段，各终端用户，各地区的分析(到2028年)

全球低分子药物研发的市场规模预测将从2022年的346亿2,182万美元，到2028年达到665亿2,718万美元，在预测期间内预计将以11.5％的年复合成长率成长。

本报告提供全球低分子药物研发市场调查，提供市场的推动因素与阻碍因素，市场机会，COVID-19影响，各市场区隔的市场分析，竞争情形，主要企业的简介等系统性资讯。

目录

第1章 摘要整理

第2章 序文

第3章 市场趋势分析

• 促进因素
• 阻碍因素
• 市场机会
• 威胁
• 终端用户分析
• 新兴市场
• COVID-19影响

第4章 波特的五力分析

第5章 全球低分子药物研发市场:各治疗领域

• 肿瘤学
• 中枢神经系统
• 心臟血管
• 呼吸系统
• 代谢疾病
• 肠胃
• 其他

第6章 全球低分子药物研发市场:各流程/阶段

• 目标ID/检验
• 点击生成和选择
• Lead Identification
• Lead Optimization

第7章 全球低分子药物研发市场:各终端用户

• 製药·生物科技企业
• 学术机构

第8章 全球低分子药物研发市场:各地区

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 其他
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他
• 南美
  • 阿根廷
  • 巴西
  • 智利
  • 其他
• 中东·非洲
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 卡达
  • 南非
  • 其他

第9章 主要发展

• 契约，伙伴关係，联盟，合资企业
• 收购·合併
• 新产品的销售
• 事业扩大
• 其他的主要策略

第10章 企业简介

• 21st Century Therapeutics Inc.
• Gilead Sciences Inc.
• BioNTech (4SC-Discovery)
• Bristol-Myers Squibb Company
• Acacia Pharma Gr
• AstraZeneca
• Agilent Technologies Inc.
• Boehringer Ingelheim GmbH
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Industries Ltd
• Johnson & Johnson
• Pfizer Inc.
• Merck KGaA
• Novartis
• Teva Pharmaceuticals

According to Stratistics MRC, the Global Small Molecule Drug Discovery Market is accounted for $ 34621.82 million 2022 and is expected to reach $ 66527.18 million by 2028 growing at a CAGR of 11.5% during the forecast period Small molecular drugs, which penetrate through the cell membrane and act on a particular cellular organelle or protein, are employed in targeted drug delivery. Due to their low molecular weight, tiny molecules medications can easily enter cells. Due to their size, simplicity in converting to an oral form, and cost-effectiveness, these molecules perform better than monoclonal antibodies and other large molecular medications.

According to the Centres for Disease Control (CDC), 6 in 10 adults suffer from a chronic condition, such as heart disease, diabetes, cancer, kidney disease, lung disease, or stroke in the US, costing US$ 3.5 trillion to the economy in the US annually for the treatment of these chronic diseases. Chronic diseases are the most significant cause of deaths worldwide, and the number is growing every year.

Market Dynamics:

Driver:

Increasing number of chronic diseases

The rise of chronic illnesses fuels the market's expansion. According to data from the British Heart Foundation from August 2022, 7.6 million persons in the UK were affected by heart or cardiovascular disease in 2021. Globally, there were 19.3 million new cases of cancer in 2020, and this figure is projected to rise to 30.2 million by 2040, according to GLOBOCAN 2020 estimates. It is anticipated that the prevalence of chronic diseases will raise treatment demand, which will ultimately boost small molecule demand. Consequently, it is anticipated to fuel the market's expansion.

Restraint:

High drug development costs and strict regulations

Over the forecast period, the market's expansion is anticipated to be constrained by high drug development costs and strict regulations for drug development.

Opportunity:

Rising technological advancements

Rising technical breakthroughs and a preference for small molecules, combined with increasing illness complications, have prompted leading players to raise their R&D expenditure, which is also functioning as a major growth factor for the market.

Threat:

Complex and costly process

Small molecule drug development is a time-consuming, difficult, and expensive process that is rife with doubt about whether a certain drug will be successful.

COVID-19 Impact

The health systems of nations have been making significant investments in R&D to tackle the COVID-19 virus. Research teams from all across the world are working to find small molecule medications for COVID-19 by testing both brand-new and off-the-shelf medications for their capacity to reduce symptoms and stop viral replication. In light of the ongoing pandemic, the need to identify a treatment for COVID-19 is thus anticipated to have a beneficial impact on the small molecule drug discovery industry.

The oncology segment is expected to be the largest during the forecast period

Based on the therapeutic area, the market is classified into Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal and Other Therapeutic Areas. The oncology segment is projected to control the global small molecule drug discovery market and most liable explanation for the majority of the share during the forecast period. Due to the rising number of small molecule medication approvals and expanding pipeline for cancer therapies, the oncology category maintained the biggest market share in 2019. Additionally, the segment's growth is being further driving by rising oncology investment.

The target id/validation segment is expected to have the highest CAGR during the forecast period

Based on the process/phase, the market is segmented into Target ID/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization. The target id/validation segment is captured to be more profitable and predicted to record a strong CAGR during the forecast period. A tiny molecule's direct molecular target, such as a protein or nucleic acid, is identified through the process of target identification. Target identification in clinical pharmacology is to determine the effectiveness of the medication molecule's target. The fundamental goal of target validation is to determine and assess a molecular target's potential for aiding in the production of medicines with therapeutic applications.

Region with highest share:

North America is anticipated to hold the highest share during the forecast period. Owing to the rising rates of different chronic diseases, including cancer, cardiovascular disease, and others, as well as the increasing acceptance of new small molecules in the area, are the main reasons propelling the market's expansion. The FDA reports that the Center for Drug Evaluation and Research (CDER) approved 48 new medications in 2019.

Region with highest CAGR:

North America small molecule drug discovery market is one of the fastest-growing regions and also records highest CAGR during the forecast period. This is due the Pharmaceutical Research and Manufacturers of America (PhRMA) member businesses continue to be at the forefront of the discovery of new medications, and the American pharmaceutical sector has long been one of the global leaders in this field. Six grants were given out by the Food and Drug Administration in 2020 to fund new clinical trials and advance the creation of pharmaceuticals for the treatment of uncommon diseases. Due to their widespread use in the drug discovery process, this will increase the demand for small molecule drug discovery.

Key players in the market

Some of the key players profiled in the Small Molecule Drug Discovery Market include 21st Century Therapeutics Inc., Gilead Sciences Inc., BioNTech (4SC-Discovery ), Bristol-Myers Squibb Company, Acacia Pharma Gr, AstraZeneca, Agilent Technologies Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, Takeda Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc., Merck KGaA, Novartis, Teva Pharmaceuticals Inc.

Key Developments:

In August 2022, BioDuro-Sundia and X-Chem, a DEL technology pioneer in small molecule drug discovery, launched DNA Encoded Compound Library (DEL) technology services in China to help more innovative pharmaceutical companies quickly discover small molecule drugs.

In July 2022, RxCelerate launched RxNfinit. It is a new small molecule discovery platform that leverages machine learning, in silico structure modeling, and combinatorial chemistry in a novel workflow to offer significant advantages over the current generation of tools to identify small molecule drugs against a wide range of protein targets.

Therapeutic Area Covered:

• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Metabolic Disorders
• Gastrointestinal
• Other Therapeutic Areas

Process/Phase Covered:

• Target ID/Validation
• Hit Generation and Selection
• Lead Identification
• Lead Optimizations

End User Covered:

• Pharmaceutical & biotechnology companies
• Academic Institutes

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Small Molecule Drug Discovery Market, By Therapeutic Area

• 5.1 Introduction
• 5.2 Oncology
• 5.3 Central Nervous System
• 5.4 Cardiovascular
• 5.5 Respiratory
• 5.6 Metabolic Disorders
• 5.7 Gastrointestinal
• 5.8 Other Therapeutic Areas

6 Global Small Molecule Drug Discovery Market, By Process/Phase

• 6.1 Introduction
• 6.2 Target ID/Validation
• 6.3 Hit Generation and Selection
• 6.4 Lead Identification
• 6.5 Lead Optimization

7 Global Small Molecule Drug Discovery Market, By End User

• 7.1 Introduction
• 7.2 Pharmaceutical&biotechnology companies
• 7.3 Academic Institutes

8 Global Small Molecule Drug Discovery Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 21st Century Therapeutics Inc.
• 10.2 Gilead Sciences Inc.
• 10.3 BioNTech (4SC-Discovery )
• 10.4 Bristol-Myers Squibb Company
• 10.5 Acacia Pharma Gr
• 10.6 AstraZeneca
• 10.7 Agilent Technologies Inc.
• 10.8 Boehringer Ingelheim GmbH
• 10.9 GlaxoSmithKline PLC
• 10.10 Takeda Pharmaceutical Industries Ltd
• 10.11 Johnson & Johnson
• 10.12 Pfizer Inc.
• 10.13 Merck KGaA
• 10.14 Novartis
• 10.15 Teva Pharmaceuticals

List of Tables

• Table 1 Global Small Molecule Drug Discovery Market Outlook, By Region (2020-2028) ($MN)
• Table 2 Global Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 3 Global Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
• Table 4 Global Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
• Table 5 Global Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
• Table 6 Global Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
• Table 7 Global Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 8 Global Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
• Table 9 Global Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 10 Global Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
• Table 11 Global Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
• Table 12 Global Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
• Table 13 Global Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
• Table 14 Global Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
• Table 15 Global Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
• Table 16 Global Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
• Table 17 Global Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
• Table 18 North America Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
• Table 19 North America Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 20 North America Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
• Table 21 North America Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
• Table 22 North America Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
• Table 23 North America Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
• Table 24 North America Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 25 North America Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
• Table 26 North America Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 27 North America Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
• Table 28 North America Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
• Table 29 North America Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
• Table 30 North America Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
• Table 31 North America Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
• Table 32 North America Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
• Table 33 North America Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
• Table 34 North America Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
• Table 35 Europe Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
• Table 36 Europe Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 37 Europe Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
• Table 38 Europe Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
• Table 39 Europe Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
• Table 40 Europe Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
• Table 41 Europe Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 42 Europe Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
• Table 43 Europe Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 44 Europe Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
• Table 45 Europe Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
• Table 46 Europe Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
• Table 47 Europe Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
• Table 48 Europe Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
• Table 49 Europe Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
• Table 50 Europe Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
• Table 51 Europe Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
• Table 52 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
• Table 53 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 54 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
• Table 55 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
• Table 56 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
• Table 57 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
• Table 58 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 59 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
• Table 60 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 61 Asia Pacific Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
• Table 62 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
• Table 63 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
• Table 64 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
• Table 65 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
• Table 66 Asia Pacific Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
• Table 67 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
• Table 68 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
• Table 69 South America Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
• Table 70 South America Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 71 South America Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
• Table 72 South America Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
• Table 73 South America Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
• Table 74 South America Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
• Table 75 South America Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 76 South America Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
• Table 77 South America Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 78 South America Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
• Table 79 South America Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
• Table 80 South America Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
• Table 81 South America Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
• Table 82 South America Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
• Table 83 South America Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
• Table 84 South America Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
• Table 85 South America Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)
• Table 86 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Country (2020-2028) ($MN)
• Table 87 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2020-2028) ($MN)
• Table 88 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Oncology (2020-2028) ($MN)
• Table 89 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2020-2028) ($MN)
• Table 90 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2020-2028) ($MN)
• Table 91 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Respiratory (2020-2028) ($MN)
• Table 92 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Metabolic Disorders (2020-2028) ($MN)
• Table 93 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2020-2028) ($MN)
• Table 94 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2020-2028) ($MN)
• Table 95 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By By Process/Phase (2020-2028) ($MN)
• Table 96 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Target ID/Validation (2020-2028) ($MN)
• Table 97 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2020-2028) ($MN)
• Table 98 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Lead Identification (2020-2028) ($MN)
• Table 99 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2020-2028) ($MN)
• Table 100 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By By End User (2020-2028) ($MN)
• Table 101 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Pharmaceutical&biotechnology companies (2020-2028) ($MN)
• Table 102 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Academic Institutes (2020-2028) ($MN)